Skip to main content

Table 3 Mean signal intensities of various proteins and peptides comparing endometrium of women with a normal pelvis versus stage I-II endometriosis (CM10 and IMAC)

From: TRIzol treatment of secretory phase endometrium allows combined proteomic and mRNA microarray analysis of the same sample in women with and without endometriosis

CM10     
SPAhigh     
M/z pvalue Mean Disease Mean Control Up/down
8898,40 0,036 4,475 1,935 up
10115,90 0,036 8,002 3,545 up
11656,79 0,036 6,899 2,721 up
11861,80 0,008 3,013 1,160 up
12186,64 0,014 0,386 0,132 up
12379,95 0,008 1,580 0,420 up
12847,34 0,023 0,668 0,228 up
13464,70 0,036 0,432 0,198 up
14659,37 0,023 2,197 1,049 up
SPAlow     
7662,79 0,036 0,190 0,362 down
8078,54 0,022 0,118 0,339 down
8949,82 0,008 1,326 0,720 up
9941,98 0,008 2,382 1,234 up
10084,76 0,022 1,900 1,096 up
11801,42 0,014 0,875 0,432 up
11835,69 0,008 0,507 0,284 up
12323,14 0,008 0,727 0,215 up
15199,86 0,014 0,010 0,088 down
IMAC     
CHCA     
M/z pvalue Mean Disease Mean Control Up/down
11163,87 0,022 0,469 0,245 up
11322,71 0,008 0,836 0,294 up
13815,44 0,014 3,281 1,411 up
15446,04 0,036 0,283 0,108 up
SPAlow     
8228,62 0,014 0,429 0,198 up